✦ LIBER ✦

Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma

✍ Scribed by Georg C. Hutterer; Pierre I. Karakiewicz; Craig Zippe; Gerson Lüdecke; Hans Boman; Marta Sanchez-Carbayo; Roberto Casella; Christine Mian; Martin G. Friedrich; Sanaa Eissa; Hideyuki Akaza; Vincenzo Serretta; Hans Hedelin; Raina Rupesh; Naoto Miyanaga; Arthur I. Sagalowsky; Paul Perrotte; Yair Lotan; Michael J. Marberger; Shahrokh F. Shariat

Book ID: 109053718
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 91 KB
Volume: 101
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2007.07352.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Urinary nuclear matrix protein 22 (NMP22

Urinary nuclear matrix protein 22 (NMP22): A diagnostic adjunct to urine cytologic examination for the detection of recurrent transitional-cell carcinoma of the bladder

✍ Jonathan H. Hughes; Ruth L. Katz; Julio Rodriguez-Villanueva; Larry Kidd; Colin 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

This study compares urine nuclear matrix protein 22 (NMP22) immunoassay and conventional urine cytologic examination for detecting recurrent transitional-cell carcinoma (TCC) of the urinary bladder. One hundred twenty-eight urine specimens from 107 patients with a history of TCC of the urinary bladd

The role of nuclear matrix protein 22 in

The role of nuclear matrix protein 22 in the detection of persistent or recurrent transitional-cell cancer of the bladder

✍ Scott W. Shelfo; Mark S. Soloway 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 467 KB

Comparison of the nuclear matrix protein

Comparison of the nuclear matrix protein 22 with voided urine cytology in the diagnosis of transitional cell carcinoma of the bladder

✍ Lekili, Murat ;Sener, Erc�ment ;Demir, Mehmet Akif ;Temeltas, G�khan ;M�ezzinogl 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 174 KB

Evaluation of a urinary assay for nuclea

Evaluation of a urinary assay for nuclear matrix protein (NMP22). A marker for transitional cell carcinoma of the bladder

✍ D.A Gornall; A Toguri 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Institutional variability in the accurac

Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder

✍ PIERRE I. KARAKIEWICZ; SERGE BENAYOUN; CRAIG ZIPPE; GERSON LÜDECKE; HANS BOMAN; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

The clinical utility of atypical cytolog

The clinical utility of atypical cytology is significantly increased in both screening and monitoring for bladder cancer when indexed with nuclear matrix protein-22

✍ Rupesh Raina; Geetu Pahlajani; Lee E. Ponsky; Ashok Agarwal; Craig D. Zippe 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB